Hologic, Inc. (HOLX) Tops Q3 EPS by 3c; Guides Q4 Above Consensus

Hologic, Inc. (NASDAQ: HOLX) reported Q3 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $632.6 million versus the consensus estimate of $621.89 million.

Hologic, Inc. sees Q4 2014 EPS of $0.36-$0.37, versus the consensus of $0.35. Hologic, Inc. sees Q4 2014 revenue of $630-640 million, versus the consensus of $625.3 million.

For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• KeyBanc on National Fuel Gas (NFG): 'P&S Growth an Underappreciated Hedge to Weak Natural Gas Prices'
• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c